(Q38866773)

English

Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3).

scientific article published on 3 June 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3). (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

1

object named as

Marco Fossati

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Giovanni Scambia

5

object named as

Giovanni Scambia

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Alexia Buzzonetti

2

object named as

Alexia Buzzonetti

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Valentina Catzola

4

object named as

Valentina Catzola

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Andrea Fattorossi

6

object named as

Andrea Fattorossi

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Giovanni Monego

3

object named as

Giovanni Monego

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Alessandra Battaglia

7

object named as

Alessandra Battaglia

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

language of work or name

0 references

publication date

3 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

138

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

343-351

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Pattern and prognostic factors in patients with malignant ascites: a retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Malignant ascites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Phenotype and antitumor activity of ascitic fluid monocytes in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Immunosuppressive factors in ascites fluids from ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Immunosuppressive effects of peritoneal fluids from ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Celecoxib Up-Regulates the Expression of the Chain of T Cell Receptor Complex in Tumor-Infiltrating Lymphocytes in Human Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Tuning inflammation and immunity by chemokine sequestration: decoys and more

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Semaphorins command cells to move

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Potent immunomodulatory effects of the trifunctional antibody catumaxomab.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Intraperitoneal administration of interleukin-2 in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Tumour-induced immune modulation of sentinel lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Differential regulation of chemokine production in human peritoneal mesothelial cells: IFN-gamma controls neutrophil migration across the mesothelium in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Lymphocytes in endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.003

7 January 2021

Identifiers

10.1016/J.YGYNO.2015.06.003

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38866773&oldid=2032980976"